Related Experiment Video
Updated: May 29, 2026
06:07
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
DNA methyltransferase assays
Renata Z Jurkowska1, Alexandre Ceccaldi, Yingying Zhang
1Biochemistry Lab, School of Engineering and Science, Jacobs University Bremen, Bremen, Germany.
Methods in Molecular Biology (Clifton, N.J.)
|September 14, 2011
Summary
This study presents three specialized DNA methyltransferase assays for enzyme characterization and inhibitor screening. These methods aid in understanding DNA methylation and developing targeted therapeutic strategies.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- DNA methyltransferases (DNMTs) are crucial enzymes involved in gene regulation.
- DNMT inhibition holds significant therapeutic potential for various diseases.
- Efficient assays are vital for studying DNMTs and discovering inhibitors.
Purpose of the Study:
- To describe three distinct DNA methyltransferase assays.
- To provide tools for enzymatic characterization and inhibitor screening.
- To facilitate research in DNA methylation and its therapeutic targeting.
Main Methods:
- Radioactive assay using labeled AdoMet and biotinylated DNA for enzyme kinetics.
- Bisulfite conversion assay for detailed analysis of DNA methylation patterns.
- Fluorescence-coupled, restriction-based assay for high-throughput inhibitor screening.
Main Results:
- Established a radioactive assay for detailed enzymatic characterization of DNMTs.
- Developed a bisulfite-based assay to precisely map DNA methylation patterns.
- Introduced a novel fluorescence assay enabling rapid screening of DNMT inhibitors.
Conclusions:
- The presented assays offer versatile methodologies for DNMT research.
- These assays are crucial for advancing the understanding and therapeutic targeting of DNMTs.
- The high-throughput assay is particularly valuable for drug discovery efforts.
